Literature DB >> 8457443

Plantar malignant melanoma in a white Caucasian population.

P K Dwyer1, R M Mackie, D C Watt, T C Aitchison.   

Abstract

Fifty-one white Caucasian patients from the west of Scotland, with stage I primary malignant melanoma arising on the plantar surface were studied. Subungual lesions were excluded from the study. Clinical and pathological features were related to survival, and compared with a group of 239 cases of clinical stage 1 melanoma of the lower limb, excluding the foot, collected in the same geographical area over the same period of time (1979-84). The average age of patients with plantar melanoma was 67 years and was significantly older than those with leg melanomas, in whom the mean age was 53 years. Twenty patients with plantar lesions had superficial spreading melanomas, 27 had acral lentiginous melanomas, and four had nodular lesions. The female:male ratio was 3:2 which was significantly different from the 7:1 female:male ratio for leg lesions. Plantar melanomas were more commonly ulcerated (57%) than were melanomas on the leg (29%) [P < 0.001]. There was no significant difference between the mean thickness of melanomas on the plantar surface and those on the leg. Nine (17%) of the patients with plantar melanomas gave a clinical history of pre-existing naevus and in 27% there was pathological evidence of a pre-existing naevus. Disease-free survival at 5 years for the population with plantar melanomas was 82, 51 and 0%, respectively, for melanomas 0-1.49, 1.5-3.49 and over 3.5 mm in thickness. This compares with 95, 71 and 46%, respectively, for leg lesions. In each thickness category patients with leg melanomas have a significantly better survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8457443     DOI: 10.1111/j.1365-2133.1993.tb15138.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

Review 1.  Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features.

Authors:  Emily A Merkel; Pedram Gerami
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

2.  Use of imiquimod for residual acral melanoma.

Authors:  Gloria R Sue; Allison Hanlon; Rossitza Lazova; Deepak Narayan
Journal:  BMJ Case Rep       Date:  2014-08-21

Review 3.  Translational pathology, genomics and the development of systemic therapies for acral melanoma.

Authors:  Yian Ann Chen; Jamie K Teer; Zeynep Eroglu; Jheng-Yu Wu; John M Koomen; Florian A Karreth; Jane L Messina; Keiran S M Smalley
Journal:  Semin Cancer Biol       Date:  2019-11-02       Impact factor: 15.707

4.  Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unit.

Authors:  Ivan R Bristow; David Ar de Berker
Journal:  J Foot Ankle Res       Date:  2010-09-28       Impact factor: 2.303

5.  A clinicopathological analysis of 153 acral melanomas and the relevance of mechanical stress.

Authors:  Yi-Shuan Sheen; Yi-Hua Liao; Ming-Hsien Lin; Jau-Shiuh Chen; Jau-Yu Liau; Yu-Ju Tseng; Chih-Hung Lee; Yih-Leong Chang; Chia-Yu Chu
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

6.  Local recurrence and metastasis in patients with malignant melanomas after surgery: A single-center analysis of 202 patients in South Korea.

Authors:  Soo Ick Cho; Jaewon Lee; Gwanghyun Jo; Sang Wha Kim; Kyung Won Minn; Ki Yong Hong; Seong Jin Jo; Kwang Hyun Cho; Byung Jun Kim; Je-Ho Mun
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

7.  PTEN Promoter Hypermethylation Is Associated with Breslow Thickness in Acral Melanoma on the Heel, Forefoot, and Hallux.

Authors:  Hae Seok Park; Jong Hoon Kim; Mi Yeon Cho; Kee Yang Chung; Mi Ryung Roh
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

8.  Malignant melanoma misdiagnosed as diabetic foot ulcer: A case report.

Authors:  Wei Gao; Dawei Chen; Xingwu Ran
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 9.  Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms.

Authors:  Anindita Bose; Gregory A Petsko; David Eliezer
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

10.  Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.

Authors:  Tung-Lin Lee; Yi-Hua Liao; Jau-Yu Liau; Yi-Shuan Sheen
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.